Treatment of Candida Infections with Amphotericin B Lipid Complex

The efficacy and renal safety of amphotericin B lipid complex (ABLC) were assessed in >900 patients with candidiasis. Overall, a favorable clinical response (cured or improved) was observed in 61% of patients infected with Candida species only, in 62% of patients infected with C. albicans, and in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2005-05, Vol.40 (Supplement-6), p.S384-S391
Hauptverfasser:	Ito, James I., Hooshmand-Rad, Roya
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Amphotericin B - therapeutic use Antifungal Agents - therapeutic use Antifungals Candida Candidemia Candidiasis Candidiasis - drug therapy Child Child, Preschool Dosage Drug Combinations Female Fungal infections Fungi Health outcomes Humans Infant Infections Lipids Lung diseases Male Medical treatment Middle Aged Patients Phosphatidylcholines - therapeutic use Phosphatidylglycerols - therapeutic use Registries Reproductive system Response rates Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!